london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

Effectiveness and possible complications of Ozurdex® as a treatment of noninfectious posterior uveitis

Poster Details

First Author: R.Kamal Salah SPAIN

Co Author(s):    E. Jimenez Rodriguez   P. Rivera de Zea               0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

We present 7 patients diagnosed with cystoid macular edema (CME) secondary to noninfectious posterior uveitis (NIPU) treated with an intravitreal dexamethasone 0,7mg implant (OZURDEX®) to study its effectiveness and possible complications.

Setting:

Hospital Virgen de la Victoria of Malaga (Spain)

Methods:

We studied 7 eyes with CME secondary to different NIPU (sarcoidosis, Irvine-Gass síndrome, Birdshot desease and idiopathic uveítis), all of them treated with an OZURDEX®. They underwent a complete ocular examination including best corrected visual acuity (BCVA), intraocular pressure, biomicroscopy, funduscopy and optical coherence tomography using a macular cube 512x128 scan.

Results:

In most cases there was an improvement of the BCVA and the macular thickness in the first 30 days and they presented a deterioration between the days 90 and 180. One patient had an elevation of intraocular pressure (IOP) controlled with 1 IOP-lowering topical medication. A pseudophakic patient had a migration of the implant into the anterior chamber reposition was done without surgery. In another patient the implant was placed on the posterior side of the lens.

Conclusions:

Ozurdex® has proven to be an effective treatment in CME secondary to noninfectious uveítis, specially in the first 4 months. The short term side effects are mainly elevation of IOP and the risks of intravitreal injections. There are other uncommon complications such as the migration of the implant to the anterior chamer or its placement in the posterior side of the lens. Further studies are needed to analyze theses uncommon complications and the long-term side effects.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy